CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Open-market sale See Remarks sold 7,043 shares at $3.02 ($21,263)
- 4 Open-market sale General Counsel sold 12,109 shares at $3.02 ($36,557)
- 4 Grant or award Chief Operating Officer acquired 407,166 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 54,734 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 47,667 shares (grant or award)
- 4 Grant or award Director acquired 49,434 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 1,477 shares at $2.88 ($4,257)
- 4 Open-market sale See Remarks sold 357 shares at $6.45 ($2,301)
- 4 Open-market sale See Remarks sold 801 shares at $6.45 ($5,163)
- 4 Open-market sale See Remarks sold 767 shares at $6.45 ($4,944)
- 4 Open-market sale CEO sold 2,253 shares at $6.45 ($14,523)
- 4 Open-market sale General Counsel sold 587 shares at $6.45 ($3,784)
- 4 Open-market sale See Remarks sold 655 shares at $6.53 ($4,276)
Page 4 of 21 · 406 filings